We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Lactate Analyzer with POC Hematocrit Compensation Launched

By LabMedica International staff writers
Posted on 10 Dec 2013
A lactate analyzer, originally developed for coaches and sportsmen, has additional features that make it suitable for further medical applications. More...


Launched by EKF Diagnostics (Cardiff, United Kingdom), the upgraded Lactate Scout+ includes built-in hematocrit compensation. This makes it suitable for a range of medical applications including cord blood lactate (CBL) analysis that can give a picture of acid-base balance at birth and is particularly recommended after high risk deliveries, fetal scalp lactate (FSL), that can be used to confirm abnormal cardiotocography values and helps to determine the need for immediate intervention in complicated births where there may be risk of insufficient fetal oxygen supply.

The in-built compensation for hematocrit (Hct) within Lactate Scout+ ensures accurate lactate measurements even at high (>50%) or low (<35%) Hct levels. The new analyzer’s Hct range is 20%–70%, which means patients with either very low Hct levels (e.g., after blood loss) or very high levels (e.g., professional athletes and neonates) can be accurately assessed. This makes Lactate Scout+ ideal for a range of medical applications. These include cardio training, weight reduction, and fitness applications which are already well established, as well as new applications in obstetrics.

EKF CEO, Julian Baines commented, “The launch of the new version of Lactate Scout+ reaffirms EKF Diagnostics’ long term expertise in lactate measurement.”

Related Links:

EKF Diagnostics



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Gold Member
Latex Test
SLE-Latex Test
New
PSA Test
Humasis PSA Card
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.